COMP <GO>
ABVX vs KNSA // GROSS PROFIT MARGIN
Abivax SA (NASDAQ) VS. Kiniksa Pharmaceuticals International plc (Class A) (NASDAQ) • 15-METRIC TALLY: ABVX 6
— KNSA 5
■ METRIC PARITY
LAST: $84.91 (-1.94%) • MKT CAP: $7.56B
gross-margins
—
LAST: $90.80 (-1.56%) • MKT CAP: $7.25B
gross-margins
88.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ABVX VS. KNSA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ABVX | KNSA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 88.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 9.90% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 95.0x | -74.00 | ABVX | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 1.78% | +0.43 | ABVX | /fcf-yield <GO> |
| Operating Margin | 13.90% | 11.40% | +2.50 | ABVX | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 8.70% | +2.20 | ABVX | /net-margins <GO> |
| Revenue Growth (YoY) | 8.80% | 60.10% | -51.30 | KNSA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 24.45 | -20.71 | KNSA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | KNSA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.0 | 59.2 | -18.20 | KNSA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.11 | -0.06 | KNSA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.5x | 109.1x | -78.60 | ABVX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.56B | $7.25B | $307.9M | ABVX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ABVX REV | KNSA REV | ABVX GROSS % | KNSA GROSS % | ABVX FCF | KNSA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $677.6M | — | 88.5% | — | $136.4M |
| FY 2024 | — | $423.2M | — | 85.6% | — | $25.4M |
| FY 2023 | — | $270.3M | — | — | — | $1.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ABVX // BETA 1.05
KNSA // BETA 1.11